当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Raipal Chatrj*
Nano biotechnology represents a cutting-edge interdisciplinary field at the intersection of nanoscience and
biotechnology. This abstract provides an overview of the transformative impact of nano biotechnology on medicine
and its far-reaching applications beyond healthcare. At the core of this field lies the manipulation and utilization
of nanoscale materials and devices to enable groundbreaking advancements in diagnostics, drug delivery, and
therapeutic interventions. In medicine, nano biotechnology has revolutionized diagnostic techniques by enhancing
sensitivity and specificity through the development of nanoscale sensors and imaging agents. These innovations have
led to earlier and more accurate disease detection, ultimately improving patient outcomes. Furthermore, the field has
ushered in a new era of targeted drug delivery, enabling the precise administration of therapeutics at the cellular and
molecular levels. This has reduced side effects and enhanced treatment efficacy, particularly in cancer therapy. The
potential of nano biotechnology is vast, and its transformative impact on medicine and various other fields is already
evident. As the field continues to evolve, it is crucial to address ethical, safety, and regulatory concerns to harness
its full potential for the betterment of society. This abstract underscores the significance of nano biotechnology in
revolutionizing medicine and its potential to reshape multiple facets of our lives, promising a future characterized by
enhanced healthcare, sustainable practices, and groundbreaking scientific discoveries.